Template:Trichomonas antibiotics: Difference between revisions
No edit summary |
ClaireLewis (talk | contribs) No edit summary |
||
| Line 12: | Line 12: | ||
====Women with HIV Infection==== | ====Women with HIV Infection==== | ||
*Metronidazole 500 mg PO BID x 7 days<ref>CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2010;59(No. RR-12)</ref> | *[[Metronidazole]] 500 mg PO BID x 7 days<ref>CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2010;59(No. RR-12)</ref> | ||
Revision as of 18:10, 4 October 2019
Non-Pregnant
- Metronidazole 2g PO once OR 500mg PO BID for 7 days [1]
- Tinidazole 2g PO once
Pregnant
Only treat if the patient is symptomatic and avoid breast feeding until 24-hrs after last dose
- Metronidazole 2g PO once[2]
Sexual Partner Treatment
- Metronidazole 500mg PO BID x 7 days OR
- Tinidazole 2g PO once
Women with HIV Infection
- Metronidazole 500 mg PO BID x 7 days[3]
- ↑ Kissinger P et al. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: An open-label, randomised controlled trial. Lancet Infect Dis 2018 Oct 5; [e-pub].
- ↑ CDC Trichomoniasis 2015. https://www.cdc.gov/std/tg2015/trichomoniasis.htm
- ↑ CDC. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2010;59(No. RR-12)